USRE34618EExpiredUtility

Injection of nicardinpine hydrochloride and process for the production thereof

50
Assignee: YAMANOUCHI PHARMA CO LTDPriority: May 22, 1984Filed: Nov 14, 1991Granted: May 24, 1994
Est. expiryMay 22, 2004(expired)· nominal 20-yr term from priority
A61K 47/26A61K 9/0019A61K 47/10A61K 31/44
50
PatentIndex Score
17
Cited by
3
References
2
Claims

Abstract

An injectable composition of nicardipine hydrochloride comprising an aqueous nicardipine hydrochloride solution containing 2-7 w/v % of polyhydric alcohol. This injectable composition can maintain its desired concentration and can be stably stored for a long period of time.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A stable, injectable composition of nicardipine hydrochloride .[.in ampoule form.]. comprising an aqueous nicardipine hydrochloride solution containing 0.04 to 0.6 W/V% nicardipine hydrochloride and 2 to 7 W/V% of a polyhydric alcohol and wherein the pH of said solution is from 2.5 to 5, and the percentage of nicardipine hydrochloride remaining in said solution after a 12 week storage period at 60° C. is between 69.24 percent and 74.39 percent. 
     
     
       2. The stable injectable composition as claimed in claim 1, wherein the polyhydric alcohol is selected from the group consisting of sorbitol, mannitol, xylitol, propylene glycol, glycerol, and inositol. .[.3. A process of producing a stable nicardipine hydrochloride injectable composition of claim 8, which process comprises dissolving nicardipine hydrochloride and a polyhydric alcohol in an amount of 2 to 7 W/V% of the whole amount of the injection in water and adjusting the pH of the solution to 2.5 to 5..]. .[.4. The process as claimed in claim 3, wherein the polyhydric alcohol is selected from the group consisting of sorbitol, 
     
     
        mannitol, xylitol, propylene glycol, glycerol and inositol..]. 5. The stable injectable composition of claim 1 wherein the aqueous nicardipine 
     
     
        solution contains 0.1 to 0.6 W/V% nicardipine hydrochloride. 6. A process of producing a stable nicardipine hydrochloride injectable composition of claim 5, which process comprises dissolving nicardipine hydrochloride and a polyhydric alcohol in an amount of 2 to 7 W/V% of the whole amount of the injectable composition in water and adjusting the pH of the solution 
     
     
        to 2.5 to 5. 7. The process as claimed in claim 6 wherein the polyhydric alcohol is selected from the group consisting of sorbitol, mannitol, xylitol, propylene glycol, glycerol, and inositol.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.